BioStock: PHI’s CEO reflects on the Company’s momentum

November 14, 2023
Language flag

Medtech company PHI has experienced a dynamic year, with multiple significant advancements resulting in a 230 per cent surge in the company’s stock price so far this year.

BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.

Read the full interview with Patrik Eschricht on biostock.se.

Latest News

Directed issue registered at the Companies Registration Office

PHI Board of Directors’ proposal on a directed issue to Altium S.A. was resolved on the extraordinary general meeting on November 15, 2023. The directed issue has now been registered at the Swedish Companies Registration Office.

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 15 november 2023

Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on November 15, 2023. The following resolutions were passed at the meeting.
Biostock-Altium-fuels-PHIs-forward-drive

BioStock: Altium fuels PHI’s forward drive

BioStock connects with Goran Dubravčić, Altium’s CEO and PHI’s newly appointed Chairman of the Board, to explore the current pivotal developments and their impact on PHI’s trajectory.
See All News